HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Cycloleucine

HCID 2901
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
52-52-8
Standard SMILES
NC1(C(=O)O)CCCC1
InChIKey
NILQLFBWTXNUOE-UHFFFAOYSA-N
Molecular formula
C6H11NO2
Average molar mass
129.16 g/mol
Monoisotopic mass
129.07897859

Overview

1-aminocyclopentanecarboxylic acid is a non-proteinogenic alpha-amino acid that is cyclopentane substituted at position 1 by amino and carboxy groups. It has a role as an EC 2.5.1.6 (methionine adenosyltransferase) inhibitor.

Names & identifiers

Preferred name
Cycloleucine
IUPAC
1-aminocyclopentane-1-carboxylic acid
English name
Cycloleucine
Molecular formula
C6H11NO2
Molecular weight
129.16

Names & synonyms

cycloleucine52-52-81-Aminocyclopentanecarboxylic acid1-Aminocyclopentane-1-carboxylic acidCycloleucin1-Amino-1-cyclopentanecarboxylic acidCYCLO-LEUCINE1-Amino-1-carboxycyclopentaneCyclopentanecarboxylic acid, 1-amino-1-Amino-cyclopentanecarboxylic acidNSC 1026CB 1639
Show more names
1-Carboxycyclopentylaminex201cb1639CYCLEU
1-Aminocyclopentanecarboxylateaminocyclopentanecarboxylic acidX 201NSC1026WR 14,997NSC-10260TQU7668EIAcid, aminocyclopentanecarboxylic

Database identifiers

CAS
52-52-8
PubChem CID
2901
DTXSID
DTXSID5024475
ChEMBL
CHEMBL295830
ChEBI
CHEBI:40547
UNII
0TQU7668EI
EC Number
200-144-6
Nikkaji
J4.131I

Properties

Computed structural propertiesFilling in

XLogP
-2.6
Topological polar surface area
63.3 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
3
Rotatable bonds
1
Heavy atoms
9
Formal charge
0
Complexity
127

Experimental & physicochemical properties

Chemical ClassesNitrogen Compounds -> Amino Carboxylic Acids
DrugsPharmaceuticals -> Listed in ZINC15
Color/FormCRYSTALS FROM ETHANOL & WATER
SolubilitySOL IN WATER APPROX 5 G/100 ML
Melting Point330 °C, DECOMP
Physical DescriptionSolid; [Merck Index] Crystalline powder; [Alfa Aesar MSDS]
Stability/Shelf LifeFORMS STABLE METAL SALTS
Dissociation Constants2.62
Collision Cross Section126.23 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
Other Experimental PropertiesMP 274 °C, DECOMP; PRISMIC CRYSTALS FROM WATER /HYDROCHLORIDE/

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H301 (94.2%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 52 reports by companies from 5 notifications to the ECHA C&L Inventory.

Hazard information

Hazards Summary · 1 item

Possesses cytostatic, immunosuppressive, and antineoplastic properties; [ChemIDplus] Evidence of neurotoxicity in experimental animals; [HSDB] Causes urine changes in 3-day intermittent intraperitoneal studies of rats; Causes muscle weakness and hemorrhage in 15-day intermittent intravenous studies of dogs; Oral administration in humans causes anorexia and nausea or vomiting; [RTECS] An irritant; Harmful by ingestion; [Alfa Aesar MSDS]

Hazard Classes and CategoriesAcute Tox. 3 (94.2%)

Toxicology

Adverse EffectsNeurotoxin - Other CNS neurotoxin
Non-Human Toxicity Excerpts · 5 items

WHEN ADDED TO CHICK EMBRYO FIBROBLAST CULTURES WHICH HAD BEEN INFECTED WITH AVIAN SARCOMA VIRUS, CYCLOLEUCINE DID NOT SIGNIFICANTLY AFFECT VIRUS YIELDS BUT INHIBITED METHYLATION OF VIRAL RNA AT 5'-TERMINAL STRUCTURES.

IN BHK CELLS INFECTED WITH VESICULAR STOMATITIS VIRUS (VSV), CYCLOLEUCINE INHIBITED VIRUS SYNTHESIS BY 99% & REDUCED SIGNIFICANTLY THE SIZE OF VSV MESSENGER RNA SPECIES.

TREATMENT OF DEVELOPING RATS RESULTED IN CHANGES OF BRAIN & SPINAL CORD PHOSPHOLIPID CONTENT & FATTY ACIDS. DECR IN ETHANOLAMINE PHOSPHOLIPID CONTENT & INCR IN SATURATED FATTY ACIDS OF ETHANOLAMINE PHOSPHOLIPID. MINOR FATTY ACIDS CHANGES IN PHOSPHATIDYL CHOLINE.

Chemistry & industry

Pharmacology

PharmacodynamicsCycloleucine has cytostatic, immunosuppressive and antineoplastic activities.
Mechanism of ActionSYNTHETIC AMINO ACID THOUGHT TO ACT AS VALINE ANTAGONIST.
Biological Half-LifeAT 0.4-0.5 MG/G PLASMA LEVEL AT 24 DAYS WAS NOT SIGNIFICANTLY DIFFERENT FROM THAT AT 1 DAY. HIGHEST DOSES (1-3 MG/G) RESULTED IN NEARLY SIMILAR PLASMA LEVELS BY 4TH DAY. T/2 IN PLASMA WAS EXTREMELY LONG.
Absorption, Distribution and Excretion · 2 items

LEVELS OF (14)C IN LIVER & PANCREAS WERE RESPECTIVELY EIGHTFOLD & TWOFOLD THOSE IN BLOOD, 15 MIN AFTER IV DOSE OF [(14)C]-1-AMINOCYCLOPENTANECARBOXYLIC ACID TO RHESUS MONKEYS. (14)C LEVELS IN THESE TISSUES WERE SIMILAR TO THOSE IN BLOOD AFTER 24 HR.

WHEN ADMIN TO MICE CYCLOLEUCINE ACCUM IN TISSUES AT LEVELS BETWEEN 0.02 & 1.29 MG/ML. MOST OF REMAINING 2% WAS ASSOC WITH PROTEIN. ACCUM AGAINST CONCN GRADIENT OCCURRED IN KIDNEY, IN SPLEEN TO GREATER EXTENT & TO MUCH GREATER DEGREE IN PANCREAS. THE DISTRIBUTION RATIOS FOR CNS TISSUE, KIDNEY & SPLEEN DID NOT CHANGE AS FUNCTION OF PLASMA CYCLOLEUCINE CONCN OR OF TIME BETWEEN 4 & 40 DAYS AFTER ADMIN TO MICE. 5 DAYS AFTER ADMIN OF CYCLOLEUCINE TO MICE, HEPATIC CYCLOLEUCINE DISTRIBUTION RATIO WAS CONSIDERABLY GREATER THAN UNITY AT THE LOWEST DOSES & INCR VARIABLY WITH INCR CYCLOLEUCINE PLASMA LEVELS.

Uses & manufacturing

Uses · 4 items

A synthetic amino acid used in amino acid transport studies and in testing for immunosuppression in mice; [Merck Index] Used as experimental tumor screening agent; [HSDB]

BIOLOGICAL TESTING MATERIALS FOR IMMUNOSUPPRESSIVE PROPERTIES IN MICE; FOR AMINO ACID TRANSPORT STUDIES

AS EXPTL TUMOR SCREENING AGENT

MEDICATION (VET)

Methods of Manufacturing · 1 item

ZELINSKY, STADNIKOFF, Z PHYSIOL CHEM 75, 350 (1911); CONNORS, ROSS, J CHEM SOC 1960, 2119; CREMLYN, J CHEM SOC 1962, 3977; SUDO, ICHIHARA, BULL CHEM SOC JAPAN 36, 34 (1963). MFR: NETHERLAND PATENT APPLICATION 6,607,754 (1966 TO ROHM & HAAS), CA 67, 73159B (1967).

Related reactions

43 records
New reaction record
HRID 166662 reaction equation
HRID 166662As reactant
HRID 181100 reaction equation
HRID 181100As reactant
HRID 254030 reaction equation
HRID 254030As reactant
HRID 276253 reaction equation
HRID 276253As reactant
HRID 276694 reaction equation
HRID 276694As reactant
HRID 276695 reaction equation
HRID 276695As reactant
HRID 276697 reaction equation
HRID 276697As reactant
HRID 276699 reaction equation
HRID 276699As reactant
PreviousPage 1 of 6

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Physicochemical properties

Melting point
320 °C · 320 °C (dec.) (lit.)
Boiling point
239.22 °C · 239.22°C (rough estimate)
Density
1.1426 · 1.1426 (rough estimate)
refractive index
1.4827 · 1.4827 (estimate)
storage temp.
Keep in dark place,Inert atmosphere,Room temperature
solubility
1 mg/mL · DMSO: < 1 mg/mL (ultrasonic) (insoluble or slightly soluble)
pka
2.38 · 2.38±0.20(Predicted)
form
Crystalline Flakes or Powder
color
White to beige
Water Solubility
5 g/100 · 5 g/100 mL
Merck
14 · 14,2734
BRN
636626 · 636626
Major Application
peptide synthesis
InChI
1S/C6H11NO2/c7-6(5(8)9)3-1-2-4-6/h1-4,7H2,(H,8,9)
InChIKey
NILQLFBWTXNUOE-UHFFFAOYSA-N
SMILES
NC1(CCCC1)C(O)=O
CAS DataBase Reference
52 · 52-52-8(CAS DataBase Reference)
EWG's Food Scores
1 · 1
FDA UNII
0 TQU7668EI · 0TQU7668EI
NCI Drug Dictionary
cycloleucine
NIST Chemistry Reference
1 · Cyclopentanecarboxylic acid, 1-amino-(52-52-8)
EPA Substance Registry System
1 · Cyclopentanecarboxylic acid, 1-amino- (52-52-8)
UNSPSC Code
12352209 · 12352209
NACRES
22 · NA.22
Symbol(GHS)
6 · GHS06
Signal word
Danger
Hazard statements
301 · H301
Precautionary statements
301 · P301+P310+P330
PPE
95 · dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Hazard Codes
Xn,Xi
Risk Statements
22 · 22
Safety Statements
22 · 22-24/25
RIDADR
2811 · UN 2811 6.1/PG 3
WGK Germany
3 · 3
RTECS
2625000 · GY2625000
TSCA
TSCA listed
HazardClass
6.1 · 6.1
PackingGroup
III
HS Code
29224999 · 29224999
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
3 Oral · Acute Tox. 3 Oral
Hazardous Substances Data
52 · 52-52-8(Hazardous Substances Data)
Toxicity
50 oral · LD50 oral in rat: 290mg/kg
Limited Quantities
5 kg · 5.0 kg (11 lbs) (solid)
Excepted Quantities
Max Inner Pack (30g or 30ml) and Max Outer Pack (1Kg or 1L)

CONSIDERABLE MYELIN SPLITTING WAS SHOWN BY ELECTRON MICROSCOPIC EXAMINATION OF THE SPINAL CORDS OF CYCLOLEUCINE-AFFECTED RATS.

For more Non-Human Toxicity Excerpts (Complete) data for CYCLOLEUCINE (10 total), please visit the HSDB record page.

Safety data

PPE
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
wgk
3
tsca
TSCA listed
rtecs
GY2625000
ridadr
UN 2811 6.1/PG 3
hs_code
29224999
Toxicity
LD50 oral in rat: 290mg/kg
risk_code
22
Signal word
Danger
Symbol(GHS)
GHS06
hazard_code
Xn,Xi
safety_code
22-24/25
hazard_class
6.1
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
packing_group
III
Hazard statements
H301
Limited Quantities
5.0 kg (11 lbs) (solid)
Excepted Quantities
Max Inner Pack (30g or 30ml) and Max Outer Pack (1Kg or 1L)
Hazard Classifications
Acute Tox. 3 Oral
Precautionary statements
P301+P310+P330
Hazardous Substances Data
52-52-8(Hazardous Substances Data)
General Manufacturing InformationCyclopentanecarboxylic acid, 1-amino-: ACTIVE
Applications · 4 items

UsesNMDA receptor antagonist, inhibits nucleic acid methylation; adrenergic agonist

UsesCycloleucine can be used as a building block to synthesize: Phosphonylmethylaminocyclopentane-1-carboxylic acid by reacting with paraformaldehyde and diethylphosphite via Kabachnik-Field′s reaction. Benzo[b]thiophene-2-carboxylic acid {1-[1-(R)-(3-morpholin-4-ylpropylcarbamoyl)-2-phenylethylcarbamoyl]cyclopentyl}-amide, (MEN14268) as potential tachykinin NK2 receptor antagonist.

UsesCycloleucine is a synthetic amino acid used in numerous biochemical transport studies

General DescriptionCycloleucine is a nonmetabolizable amino acid widely used as a building block in peptide synthesis.

Upstream & downstream products

Downstream products

Methyl 1-amino-1-cyclopentanecarboxylateMethyl 1-amino-1-cyclopentanecarboxylate hydrochloride

Additional notes

DefinitionChEBI: A non-proteinogenic alpha-amino acid that is cyclopentane substituted at position 1 by amino and carboxy groups.